Han, J. X., Koh, M. J., Boussi, L., Sorial, M., McCabe, S. M., Peng, L., Singh, S., Eche-Ugwu, I. J., Gabler, J., Fernandez Turizo, M. J., MacVicar, C. T., Garg, A. R., Disciullo, A., Chopra, K., Lenart, A. W., Nwodo, E., Barnes, J. A., Koh, M. J., Miranda, E. C. M., … Jain, S. (2024). Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014674

Ryu Tiger, Y. K., Jain, S., Barta, S. K., Tolu, S., Estrella, B., Sawas, A., Lue, J. K., Francescone, M. M., Pro, B., & Amengual, J. E. (2024). Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia & Lymphoma, 65(6), 736–745. https://doi.org/10.1080/10428194.2024.2329996